title: Evaluating three hundred and fifty-two admissions and predictors of re-admissions for epistaxis - is it time to re-evaluate tranexamic acid in epistaxis?
authors.affiliation: ENT Dept, Princess Royal Hospital, Telford, UK.
authors.forename: S
authors.initials: S
authors.lastname: Jervis
authors.affiliation: ENT Dept, Princess Royal Hospital, Telford, UK.
authors.forename: T
authors.initials: T
authors.lastname: Saunders
authors.affiliation: Department of Mathematics and Computing, Keele University, Stoke-on-Trent, UK.
authors.forename: J
authors.initials: J
authors.lastname: Belcher
authors.affiliation: ENT Dept, Princess Royal Hospital, Telford, UK.
authors.forename: D
authors.initials: D
authors.lastname: Skinner
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000933:Antifibrinolytic Agents / Q000627:therapeutic use*; D004844:Epistaxis / Q000188:drug therapy*; D005260:Female; D006760:Hospitalization; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D012307:Risk Factors; D014148:Tranexamic Acid / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000933:Antifibrinolytic Agents; D014148:Tranexamic Acid